The landscape of dementia diagnosis has evolved considerably with the arrival of innovative biomarkers, which include amyloid PET scans, tau imaging, and blood-dependent checks which will detect Alzheimer's pathology decades before symptoms arise. Though these technological innovations characterize amazing progress in knowing neurodegenerative ailments, they've not diminished the cruc... https://hughn531ozj2.blogsuperapp.com/profile